Search Orphan Drug Designations and Approvals
-
Generic Name: | P1, P4-Di(uridine 5'-tetraphosphate), tetrasodium salt |
---|---|
Date Designated: | 10/27/1998 |
Orphan Designation: | Treatment of cystic fibrosis. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Inspire Pharmaceuticals, Inc. 4222 Emperor Blvd., Suite 470 Durham, North Carolina 27703 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-